Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.31
-0.27 (-4.84%)
Oct 10, 2025, 4:00 PM EDT - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $55.96 million as of October 10, 2025. Its market cap has decreased by -27.00% in one year.
Market Cap
55.96M
Enterprise Value
50.28M
1-Year Change
-27.00%
Ranking
Category
Stock Price
$5.31
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $55.96M, a decrease of -55.28%. That is a compound annual growth rate of -40.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 55.96M | 18.92% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |